{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:04:48Z","timestamp":1766901888355,"version":"3.48.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11069-y","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:13:47Z","timestamp":1758957227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the role of 14-3-3\u0220 protein in rheumatoid arthritis: from molecular dysregulation to therapeutic Redirection"],"prefix":"10.1007","volume":"52","author":[{"given":"Dhrita","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-7790","authenticated-orcid":false,"given":"Kousik","family":"Maparu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"11069_CR1","doi-asserted-by":"publisher","unstructured":"Khan S, Mohan K, Muzammil S, Alam MA, Khayyam KU (2023) Current Prospects in Rheumatoid Arthritis: Pathophysiology, Genetics, and Treatments. Recent Adv Antiinfect Drug Discov. Apr 6. doi: 10.2174\/2772434418666230406083149. Epub ahead of print. https:\/\/doi.org\/10.2174\/2772434418666230406083149","DOI":"10.2174\/2772434418666230406083149"},{"issue":"10","key":"11069_CR2","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"GBD 2021 Rheumatoid Arthritis Collaborators","year":"2023","unstructured":"GBD 2021 Rheumatoid Arthritis Collaborators (2023) Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol 5(10):e594\u2013e610. https:\/\/doi.org\/10.1016\/S2665-9913(23)00211-4","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"11069_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/ar2969","volume":"12","author":"AW Morgan","year":"2010","unstructured":"Morgan AW, Robinson JI, Conaghan PG, Martin SG, Hensor EM, Morgan MD, Steiner L, Erlich HA, Gooi HC, Barton A, Worthington J, Emery P ((2010)) Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3\/TNFAIP3, STAT4 and TRAF1\/C5 in an inception cohort. Arthritis Res Ther 12(2):R57. https:\/\/doi.org\/10.1186\/ar2969","journal-title":"Arthritis Res Ther"},{"key":"11069_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221125","author":"JA Maisha","year":"2023","unstructured":"Maisha JA, El-Gabalawy H, O\u2019Neil L (2023) Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1221125","journal-title":"Front Immunol"},{"issue":"3","key":"11069_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/qjmed\/hcp165","volume":"103","author":"YW Song","year":"2010","unstructured":"Song YW, Kang EH (2010) Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM 103(3):139\u2013146. https:\/\/doi.org\/10.1093\/qjmed\/hcp165","journal-title":"QJM"},{"key":"11069_CR6","unstructured":"Chauhan K, Jandu JS, Brent LH et al Rheumatoid Arthritis. [Updated 2023 May 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441999\/"},{"key":"11069_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13075-018-1750-5","volume":"20","author":"NMT Roodenrijs","year":"2018","unstructured":"Roodenrijs NMT, de Hair MJH, Wheater G et al (2018) The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies. Arthritis Res Ther 20:256. https:\/\/doi.org\/10.1186\/s13075-018-1750-5","journal-title":"Arthritis Res Ther"},{"key":"11069_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/sj.cr.7290291","volume":"15","author":"P Mhawech","year":"2005","unstructured":"Mhawech P (2005) 14-3-3 proteins\u2014an update. Cell Res 15:228\u2013236. https:\/\/doi.org\/10.1038\/sj.cr.7290291","journal-title":"Cell Res"},{"issue":"1","key":"11069_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43(1):32\u201340. https:\/\/doi.org\/10.1002\/ana.410430109","journal-title":"Ann Neurol"},{"issue":"1","key":"11069_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010123","volume":"23","author":"M Kadiri","year":"2021","unstructured":"Kadiri M, Charbonneau M, Lalanne C, Harper K, Balg F, Marotta A, Dubois CM (2021) 14-3-3\u03b7 promotes invadosome formation via the FOXO3-Snail axis in rheumatoid arthritis fibroblast-like synoviocytes. Int J Mol Sci 23(1):123. https:\/\/doi.org\/10.3390\/ijms23010123","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11069_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40744-020-00219-2","volume":"7","author":"EG Favalli","year":"2020","unstructured":"Favalli EG (2020) Understanding the role of Interleukin-6 (IL-6) in the joint and beyond: a comprehensive review of IL-6 inhibition for the management of rheumatoid arthritis. Rheumatol Ther 7(3):473\u2013516. https:\/\/doi.org\/10.1007\/s40744-020-00219-2","journal-title":"Rheumatol Ther"},{"issue":"7","key":"11069_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.semcdb.2011.08.006","volume":"22","author":"FC Denison","year":"2011","unstructured":"Denison FC, Paul AL, Zupanska AK, Ferl RJ (2011) 14-3-3 proteins in plant physiology. Semin Cell Dev Biol 22(7):720\u2013727. https:\/\/doi.org\/10.1016\/j.semcdb.2011.08.006","journal-title":"Semin Cell Dev Biol"},{"key":"11069_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1146\/annurev.pharmtox.40.1.617","volume":"40","author":"H Fu","year":"2000","unstructured":"Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40:617\u2013647. https:\/\/doi.org\/10.1146\/annurev.pharmtox.40.1.617","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"11069_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12964-023-01420-w","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yan M, Yu Y et al (2024) 14-3-3\u03b5: a protein with complex physiology function but promising therapeutic potential in cancer. Cell Commun Signal 22:72. https:\/\/doi.org\/10.1186\/s12964-023-01420-w","journal-title":"Cell Commun Signal"},{"issue":"7","key":"11069_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30624","volume":"125","author":"ZY Low","year":"2024","unstructured":"Low ZY, Yip AJW, Chan AML, Choo WS (2024) 14-3-3 family of proteins: biological implications, molecular interactions, and potential intervention in cancer, virus and neurodegeneration disorders. J Cell Biochem 125(7):e30624. https:\/\/doi.org\/10.1002\/jcb.30624","journal-title":"J Cell Biochem"},{"issue":"6","key":"11069_CR16","first-page":"6710","volume":"10","author":"G Zhu","year":"2017","unstructured":"Zhu G, Li G, Zhang M, Zhao S, Wang T, Wei Y, Xue Y (2017) Expression of 14-3-3 beta in gastric cancer and its correlation with clinicopathological features. Int J Clin Exp Pathol 10(6):6710\u20136718","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"11069_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ph13120441","volume":"13","author":"G Aljabal","year":"2020","unstructured":"Aljabal G, Yap BK (2020) 14-3-3\u03c3 and its modulators in cancer. Pharmaceuticals (Basel) 13(12):441. https:\/\/doi.org\/10.3390\/ph13120441","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"11069_CR18","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/pmic.201000449","volume":"11","author":"CW Tseng","year":"2011","unstructured":"Tseng CW, Yang JC, Chen CN, Huang HC, Chuang KN, Lin CC, Lai HS, Lee PH, Chang KJ, Juan HF (2011) Identification of 14-3-3\u03b2 in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker. Proteomics 11(12):2423\u20132439. https:\/\/doi.org\/10.1002\/pmic.201000449","journal-title":"Proteomics"},{"issue":"10","key":"11069_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5483\/BMBRep.2020.53.10.158","volume":"53","author":"E Cho","year":"2020","unstructured":"Cho E, Park JY (2020) Emerging roles of 14-3-3\u03b3 in the brain disorder. BMB Rep 53(10):500\u2013511. https:\/\/doi.org\/10.5483\/BMBRep.2020.53.10.158","journal-title":"BMB Rep"},{"issue":"4","key":"11069_CR20","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1021\/jacsau.3c00774","volume":"4","author":"M Varl\u0131","year":"2024","unstructured":"Varl\u0131 M, Bhosle SR, Kim E, Yang Y, Ta\u015f I, Zhou R, Pulat S, Gamage CD, Park SY, Ha HH, Kim H (2024) Usnic acid targets 14-3-3 proteins and suppresses cancer progression by blocking substrate interaction. JACS Au 4(4):1521\u20131537","journal-title":"JACS Au"},{"issue":"1","key":"11069_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/sj.emboj.7600774","volume":"25","author":"S Sato","year":"2006","unstructured":"Sato S, Chiba T, Sakata E, Kato K, Mizuno Y, Hattori N, Tanaka K (2006) 14-3\u20103\u03b7 is a novel regulator of parkin ubiquitin ligase. EMBO J 25(1):211\u2013221. https:\/\/doi.org\/10.1038\/sj.emboj.7600774","journal-title":"EMBO J"},{"issue":"9","key":"11069_CR22","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s10067-020-05033-3","volume":"39","author":"N Hammam","year":"2020","unstructured":"Hammam N, Gamal NM, Elzohri MH, Elsonbaty AM, Rashed AM, Eldaly ZH, Tarik D, Gheita TA (2020) Serum 14-3-3\u03b7 protein is associated with clinical and serologic features of Sj\u00f6gren\u2019s syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis. Clin Rheumatol 39(9):2603\u20132610. https:\/\/doi.org\/10.1007\/s10067-020-05033-3","journal-title":"Clin Rheumatol"},{"key":"11069_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/376188a0","volume":"376","author":"B Xiao","year":"1995","unstructured":"Xiao B, Smerdon S, Jones D et al (1995) Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376:188\u2013191. https:\/\/doi.org\/10.1038\/376188a0","journal-title":"Nature"},{"issue":"7","key":"11069_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30624","volume":"125","author":"ZY Low","year":"2024","unstructured":"Low ZY, Yip AJ, Chan AM, Choo WS (2024) 14-3\u20103 family of proteins: biological implications, molecular interactions, and potential intervention in cancer, virus and neurodegeneration disorders. J Cell Biochem 125(7):e30624. https:\/\/doi.org\/10.1002\/jcb.30624","journal-title":"J Cell Biochem"},{"key":"11069_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0070-2153(05)67009-3","volume":"67","author":"D Thomas","year":"2005","unstructured":"Thomas D, Guthridge M, Woodcock J, Lopez A (2005) 14-3-3 protein signaling in development and growth factor responses. Curr Top Dev Biol 67:285\u2013303. https:\/\/doi.org\/10.1016\/S0070-2153(05)67009-3","journal-title":"Curr Top Dev Biol"},{"issue":"8","key":"11069_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2217\/bmm-2017-0385","volume":"12","author":"T Zeng","year":"2018","unstructured":"Zeng T, Tan L (2018) 14-3-3\u03b7 protein: a promising biomarker for rheumatoid arthritis. Biomark Med 12(8):917\u2013925. https:\/\/doi.org\/10.2217\/bmm-2017-0385","journal-title":"Biomark Med"},{"issue":"10","key":"11069_CR27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/bies.1134","volume":"23","author":"MJ Van Hemert","year":"2001","unstructured":"Van Hemert MJ, Steensma HY, van Heusden GP (2001) 14-3\u20103 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23(10):936\u2013946. https:\/\/doi.org\/10.1002\/bies.1134","journal-title":"Bioessays"},{"issue":"1","key":"11069_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-024-00370-4","volume":"12","author":"R Zhou","year":"2024","unstructured":"Zhou R, Hu W, Ma PX, Liu CJ (2024) Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases. Bone Res 12(1):58. https:\/\/doi.org\/10.1038\/s41413-024-00370-4","journal-title":"Bone Res"},{"issue":"8","key":"11069_CR29","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F (2007) Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et biophysica acta (BBA)-molecular cell research 1773(8):1263\u20131284. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.10.001","journal-title":"Biochimica et biophysica acta (BBA)-molecular cell research"},{"issue":"32","key":"11069_CR30","doi-asserted-by":"publisher","first-page":"29819","DOI":"10.1074\/jbc.C300182200","volume":"278","author":"N Dumaz","year":"2003","unstructured":"Dumaz N, Marais R (2003) Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J Biol Chem 278(32):29819\u201329823. https:\/\/doi.org\/10.1074\/jbc.C300182200","journal-title":"J Biol Chem"},{"key":"11069_CR31","doi-asserted-by":"publisher","unstructured":"Gardino AK, Yaffe MB 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. InSeminars in cell & developmental biology 2011 Sep 1 (Vol. 22, No. 7, pp. 688\u2013695). Academic Press. https:\/\/doi.org\/10.1016\/j.semcdb.2011.09.008","DOI":"10.1016\/j.semcdb.2011.09.008"},{"key":"11069_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109442","volume":"65","author":"D Heras-Sandoval","year":"2020","unstructured":"Heras-Sandoval D, P\u00e9rez-Rojas JM, Pedraza-Chaverri J (2020) Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases. Cell Signal 65:109442. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109442","journal-title":"Cell Signal"},{"issue":"16","key":"11069_CR33","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1111\/febs.15215","volume":"287","author":"D Kalabova","year":"2020","unstructured":"Kalabova D, Filandr F, Alblova M, Petrvalska O, Horvath M, Man P, Obsil T, Obsilova V (2020) 14-3-3 protein binding blocks the dimerization interface of caspase-2. FEBS J 287(16):3494\u20133510. https:\/\/doi.org\/10.1111\/febs.15215","journal-title":"FEBS J"},{"issue":"6","key":"11069_CR34","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1101\/gad.1388806","volume":"20","author":"H Jian","year":"2006","unstructured":"Jian H, Shen X, Liu I, Semenov M, He XI, Wang XF (2006) Smad3-dependent nuclear translocation of \u03b2-catenin is required for TGF-\u03b21-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 20(6):666\u2013674","journal-title":"Genes Dev"},{"key":"11069_CR35","doi-asserted-by":"publisher","unstructured":"Freeman AK, Morrison DK 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. InSeminars in cell & developmental biology 2011 Sep 1 (Vol. 22, No. 7, pp. 681\u2013687). Academic Press. https:\/\/doi.org\/10.1016\/j.semcdb.2011.08.009","DOI":"10.1016\/j.semcdb.2011.08.009"},{"issue":"7","key":"11069_CR36","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1021\/pr9011377","volume":"9","author":"S Zuo","year":"2010","unstructured":"Zuo S, Xue Y, Tang S, Yao J, Du R, Yang P, Chen X (2010) 14-3-3 epsilon dynamically interacts with key components of mitogen-activated protein kinase signal module for selective modulation of the TNF-\u03b1-induced time course-dependent NF-\u03baB activity. J Proteome Res 9(7):3465\u20133478. https:\/\/doi.org\/10.1021\/pr9011377","journal-title":"J Proteome Res"},{"key":"11069_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105236","volume":"163","author":"CC Munier","year":"2021","unstructured":"Munier CC, Ottmann C, Perry MW (2021) 14-3-3 modulation of the inflammatory response. Pharmacol Res 163:105236. https:\/\/doi.org\/10.1016\/j.phrs.2020.105236","journal-title":"Pharmacol Res"},{"key":"11069_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102392","volume":"110","author":"MA Van Delft","year":"2020","unstructured":"Van Delft MA, Huizinga TW (2020) An overview of autoantibodies in rheumatoid arthritis. J Autoimmun 110:102392. https:\/\/doi.org\/10.1016\/j.jaut.2019.102392","journal-title":"J Autoimmun"},{"issue":"3","key":"11069_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.509","volume":"5","author":"Y Gao","year":"2024","unstructured":"Gao Y, Zhang Y, Liu X (2024) Rheumatoid arthritis: pathogenesis and therapeutic advances. MedComm 5(3):e509. https:\/\/doi.org\/10.1002\/mco2.509","journal-title":"MedComm"},{"key":"11069_CR40","doi-asserted-by":"publisher","first-page":"790122","DOI":"10.3389\/fimmu.2021.790122","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Guo S, Schrodi SJ, He D (2021) Molecular and cellular heterogeneity in rheumatoid arthritis: mechanisms and clinical implications. Front Immunol 12:790122. https:\/\/doi.org\/10.3389\/fimmu.2021.790122","journal-title":"Front Immunol"},{"issue":"1","key":"11069_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","volume":"181","author":"MS Maddur","year":"2012","unstructured":"Maddur MS, Miossec P, Kaveri SV, Bayry J (2012) Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 181(1):8\u201318. https:\/\/doi.org\/10.1016\/j.ajpath.2012.03.044","journal-title":"Am J Pathol"},{"issue":"7","key":"11069_CR42","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/microorganisms12071387","volume":"12","author":"P Ermencheva","year":"2024","unstructured":"Ermencheva P, Kotov G, Shumnalieva R, Velikova T, Monov S (2024) Exploring the role of the Microbiome in rheumatoid Arthritis\u2014A. Crit Rev Microorganisms 12(7):1387. https:\/\/doi.org\/10.3390\/microorganisms12071387","journal-title":"Crit Rev Microorganisms"},{"issue":"2","key":"11069_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020905","volume":"23","author":"S Jang","year":"2022","unstructured":"Jang S, Kwon EJ, Lee JJ (2022) Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci 23(2):905. https:\/\/doi.org\/10.3390\/ijms23020905","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11069_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jor.24457","volume":"38","author":"JE Woodell-May","year":"2020","unstructured":"Woodell-May JE, Sommerfeld SD (2020) Role of inflammation and the immune system in the progression of osteoarthritis. J Orthop Res 38(2):253\u2013257. https:\/\/doi.org\/10.1002\/jor.24457","journal-title":"J Orthop Res"},{"issue":"20","key":"11069_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222010922","volume":"22","author":"N Kondo","year":"2021","unstructured":"Kondo N, Kuroda T, Kobayashi D (2021) Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci 22(20):10922. https:\/\/doi.org\/10.3390\/ijms222010922","journal-title":"Int J Mol Sci"},{"issue":"9","key":"11069_CR46","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4155\/fmc.15.55","volume":"7","author":"CJ Malemud","year":"2015","unstructured":"Malemud CJ (2015) The PI3K\/Akt\/PTEN\/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? Future Med Chem 7(9):1137\u20131147. https:\/\/doi.org\/10.4155\/fmc.15.55","journal-title":"Future Med Chem"},{"issue":"3","key":"11069_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cyto.2009.08.002","volume":"48","author":"G Huang","year":"2009","unstructured":"Huang G, Shi LZ, Chi H (2009) Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination. Cytokine 48(3):161\u2013169. https:\/\/doi.org\/10.1016\/j.cyto.2009.08.002","journal-title":"Cytokine"},{"issue":"2","key":"11069_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/antib12020030","volume":"12","author":"S G\u00f3mez-Melero","year":"2023","unstructured":"G\u00f3mez-Melero S, Caballero-Villarraso J (2023) Ccr6 as a potential target for therapeutic antibodies for the treatment of inflammatory diseases. Antibodies 12(2):30. https:\/\/doi.org\/10.3390\/antib12020030","journal-title":"Antibodies"},{"issue":"5\u20136","key":"11069_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1759720X18776224","volume":"10","author":"CJ Malemud","year":"2018","unstructured":"Malemud CJ (2018) The role of the JAK\/STAT signal pathway in rheumatoid arthritis. Ther Adv Musculoskelet Dis 10(5\u20136):117\u2013127. https:\/\/doi.org\/10.1177\/1759720X18776224","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"11069_CR50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/ijms18050905","volume":"18","author":"Y Araki","year":"2017","unstructured":"Araki Y, Mimura T (2017) Matrix metalloproteinase gene activation resulting from disordred epigenetic mechanisms in rheumatoid arthritis. Int J Mol Sci 18(5):905. https:\/\/doi.org\/10.3390\/ijms18050905","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11069_CR51","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.berh.2019.01.010","volume":"32","author":"O Shovman","year":"2018","unstructured":"Shovman O, Gilburd B, Watad A, Amital H, Langevitz P, Bragazzi NL, Adawi M, Perez D, Bornstein G, Grossman C, Lidar M (2018) The diagnostic value of 14-3-3\u03b7 protein levels in patients with rheumatoid arthritis. Best Pract Res Clin Rheumatol 32(4):610\u2013617. https:\/\/doi.org\/10.1016\/j.berh.2019.01.010","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"11069_CR52","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/sj.bjc.6600858","volume":"88","author":"T Ohshiba","year":"2003","unstructured":"Ohshiba T, Miyaura C, Inada M, Ito A (2003) Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis. Br J Cancer 88(8):1318\u20131326. https:\/\/doi.org\/10.1038\/sj.bjc.6600858","journal-title":"Br J Cancer"},{"issue":"9","key":"11069_CR53","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1111\/jcmm.16490","volume":"25","author":"J Liu","year":"2021","unstructured":"Liu J, Cao S, Ding G, Wang B, Li Y, Zhao Y, Shao Q, Feng J, Liu S, Qin L, Xiao Y (2021) The role of 14-3\u20103 proteins in cell signalling pathways and virus infection. J Cell Mol Med 25(9):4173\u20134182. https:\/\/doi.org\/10.1111\/jcmm.16490","journal-title":"J Cell Mol Med"},{"issue":"6","key":"11069_CR54","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5114\/reum.2022.123669","volume":"60","author":"Y Adel","year":"2022","unstructured":"Adel Y, Sadeq Y (2022) 14-3-3\u03b7 protein is associated with disease activity and osteoporosis in patients with rheumatoid arthritis. Reumatologia 60(6):384. https:\/\/doi.org\/10.5114\/reum.2022.123669","journal-title":"Reumatologia"},{"issue":"1","key":"11069_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-2110-9","volume":"22","author":"G Trimova","year":"2020","unstructured":"Trimova G, Yamagata K, Iwata S, Hirata S, Zhang T, Uemura F, Satoh M, Biln N, Nakayamada S, Maksymowych WP, Tanaka Y (2020) Tumour necrosis factor alpha promotes secretion of 14-3-3\u03b7 by inducing necroptosis in macrophages. Arthritis Res Ther 22(1):24. https:\/\/doi.org\/10.1186\/s13075-020-2110-9","journal-title":"Arthritis Res Ther"},{"key":"11069_CR56","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15063","author":"SC Shapiro","year":"2021","unstructured":"Shapiro SC (2021) Biomarkers in rheumatoid arthritis. Cureus. https:\/\/doi.org\/10.7759\/cureus.15063","journal-title":"Cureus"},{"issue":"1","key":"11069_CR57","doi-asserted-by":"publisher","first-page":"1497748","DOI":"10.1155\/2022\/1497748","volume":"2022","author":"DS Alashkar","year":"2022","unstructured":"Alashkar DS, Elkhouly RM, Abd Elnaby AY, Nada DW (2022) Will 14-3\u20103\u03b7 be a new diagnostic and prognostic biomarker in rheumatoid arthritis? A prospective study of its utility in early diagnosis and response to treatment. Autoimmune Dis 2022(1):1497748. https:\/\/doi.org\/10.1155\/2022\/1497748","journal-title":"Autoimmune Dis"},{"issue":"1","key":"11069_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13075-020-02405-7","volume":"23","author":"S Mun","year":"2021","unstructured":"Mun S, Lee J, Park M, Shin J, Lim MK, Kang HG (2021) Serum biomarker panel for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 23(1):31. https:\/\/doi.org\/10.1186\/s13075-020-02405-7","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"11069_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4078\/jrd.2024.0110","volume":"32","author":"R Subedi","year":"2025","unstructured":"Subedi R, Misbah A, Najada AA, Ocon AJ (2025) Evaluation of 14-3-3eta protein as a diagnostic biomarker in the initial assessment of inflammatory arthritis. J Rheum Dis 32(2):130\u2013135. https:\/\/doi.org\/10.4078\/jrd.2024.0110","journal-title":"J Rheum Dis"},{"issue":"11","key":"11069_CR60","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/1756-185X.13921","volume":"23","author":"D Wang","year":"2020","unstructured":"Wang D, Cui Y, Lei H, Cao D, Tang G, Huang H, Yuan T, Rao L, Mo B (2020) Diagnostic accuracy of 14-3-3 \u03b7 protein in rheumatoid arthritis: a meta-analysis. Int J Rheum Dis 23(11):1443\u20131451. https:\/\/doi.org\/10.1111\/1756-185X.13921","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"11069_CR61","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1021\/acs.jmedchem.7b00574","volume":"61","author":"LM Stevers","year":"2018","unstructured":"Stevers LM, Sijbesma E, Botta M, MacKintosh C, Obsil T, Landrieu I, Cau Y, Wilson AJ, Karawajczyk A, Eickhoff J, Davis J, Hann M, O\u2019Mahony G, Doveston RG, Brunsveld L, Ottmann C (2018) Modulators of 14-3-3 protein-protein interactions. J Med Chem 61(9):3755\u20133778. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00574","journal-title":"J Med Chem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11069-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11069-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11069-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:03:14Z","timestamp":1766898194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11069-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11069"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11069-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,9,27]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declared the absence of any financial or personal conflicts about this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"956"}}